News
Zepbound beats Wegovy for weight loss
Digest more
22h
MedPage Today on MSNZepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ...Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who ...
Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results